Start of main content
Pharma & Life Sciences | Newsletter February 2024
| Publications | Pharma & Life Sciences
In the first edition of Andersen Iberia’s Pharma & Life Sciences Newsletter, we have collected the main news on legislation, compliance, labor, tax and industrial and intellectual property in the sector.
Aware of the importance that the Pharma & Lifesciences sector has in our economy, at Andersen Iberia we have formed a homogeneous group of top professionals who know the industry to perfection and who can cover all the needs of companies linked to this industry.
Content
-The substantive reform of EU pharmaceutical regulation, Juan Ignacio Alonso
-Criminal liability of the legal entity in the pharmaceutical sector, María Victoria Vega and Esmeralda Iranzo
-Review of obligations to be fulfilled by companies in 2024, Victoria Caldevilla
-The need to review the implementation of technologies for the use of biometric data for time and attendance or access control, María Suárez
-Parallel imports of medicines: repackaged or relabelled?, José Garrido
-The creation of the European Health Data Space as a driver of innovation, Isabel Martínez
-VAT on the transfer of vehicles to employees, Jesús Alemany
You can read the full magazine here.
End of main content